Evidence map›Paper›PMID 12486112›Full record

ArticleThe Journal of cell biology2002

Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy.

Sudhiranjan Gupta, Nicole H Purcell, Anning Lin, Subha Sen

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 129 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Crystal structure of human V-1 in the apo form.Acta crystallographica. Section F, Structural biology communications · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. V-1 regulates capping protein activity in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Capping protein regulators fine-tune actin assembly dynamics.Nature reviews. Molecular cell biology · 2014
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sudhiranjan GuptaDepartment of Molecular Cardiology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Nicole H Purcell
Anning Lin
Subha Sen
Cleveland Clinic · USUniversity of Chicago · US

Funding

INITIATION OF MYOCARDIAL HYPERTROPHY IN HYPERTENSIONR01HL047794 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI SEN, SUBHA · 1994 to 2008
$3.3M
Regulation of I kappa B Kinase in ApoptosisR01CA092650 · NCI · UNIVERSITY OF CHICAGO · PI LIN, ANNING · 2001 to 2005
$1.3M
NCI NIH HHS R01 CA092650NCI NIH HHS R01 CA92650NHLBI NIH HHS HL R01 47794
6 · The paper itself

Abstract

The transcription factor nuclear factor-kappaB (NF-kappaB) regulates expression of a variety of genes involved in immune responses, inflammation, proliferation, and programmed cell death (apoptosis). Here, we show that in rat neonatal ventricular cardiomyocytes, activation of NF-kappaB is involved in the hypertrophic response induced by myotrophin, a hypertrophic activator identified from spontaneously hypertensive rat heart and cardiomyopathic human hearts. Myotrophin treatment stimulated NF-kappaB nuclear translocation and transcriptional activity, accompanied by IkappaB-alpha phosphorylation and degradation. Consistently, myotrophin-induced NF-kappaB activation was enhanced by wild-type IkappaB kinase (IKK) beta and abolished by the dominant-negative IKKbeta or a general PKC inhibitor, calphostin C. Importantly, myotrophin-induced expression of two hypertrophic genes (atrial natriuretic factor [ANF] and c-myc) and also enhanced protein synthesis were partially inhibited by a potent NF-kappaB inhibitor, pyrrolidine dithio-carbamate (PDTC), and calphostin C. Expression of the dominant-negative form of IkappaB-alpha or IKKbeta also partially inhibited the transcriptional activity of ANF induced by myotrophin. These findings suggest that the PKC-IKK-NF-kappaB pathway may play a critical role in mediating the myotrophin-induced hypertrophic response in cardiomyocytes.

Indexed as

AlkaloidsAnimalsAnimals, NewbornBenzophenanthridinesBlotting, NorthernBlotting, WesternCell NucleusCells, CulturedCytoplasmDNA, ComplementaryDose-Response Relationship, DrugEnzyme ActivationGenes, DominantGrowth SubstancesHypertrophyI-kappa B ProteinsAlkaloidsBenzophenanthridinescalphostin CchelerythrineDNA, ComplementaryGrowth SubstancesI-kappa B ProteinsIntercellular Signaling Peptides and ProteinsLuciferasesmyotrophinNaphthalenesNF-kappa BNF-KappaB Inhibitor alphaNFKBIA protein, humanNfkbia protein, ratPhenanthridinesProtein Kinase CRNA, Messenger

Identifiers

PMID12486112
PMCPMC2173971
OpenAlexW2102389608

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.